Correlating programmed death ligand 1 (PD-L1) expression, mismatch repair deficiency, and outcomes across tumor types: implications for immunotherapy

Oncotarget
Seung Tae KimJeeyun Lee

Abstract

The identification of biomarkers associated with response to therapeutic agents is central to optimizing patient outcomes. Expression of the immune checkpoint proteins PD-1/L1, and DNA mismatch repair deficiency (dMMR) status may be predictive response biomarkers for immunotherapies, but their overlap requires further study. We prospectively conducted PD-L1 and MMR immunohistochemistry (IHC) on 430 consecutive patients with advanced gastrointestinal (GI) cancers, genitourinary (GU) cancers or rare cancers between June 2012 and March 2016. Overall 393/430 (91.4%) patients were evaluable for PD-L1 expression by IHC. The frequency of tumor PD-L1 positivity (PD-L1+) was 16.5% (65/393). Among anatomic tumor sites PD-L1+ was 28.6% in melanoma, 22.2% in GC, 20.9% in CRC, 12.5% in BTC, 7.1% in GU cancer, 6.7% in HCC, 0% in pancreatic cancer and 0% in sarcoma. Among the 394 evaluable for MLH1/MSH2 expression cases, 18 patients (4.5%) had dMMR tumors. The dMMR was most common in GC (7.1%) followed by 6.7% in HCC, 4.4% in CRC, and 2.7% in sarcoma. Of the 365 patients evaluable for both PD-L1 and MLH1/MSH2 expression, there was a significant association between the PD-L1 expression and MLH1/MSH2 loss (P = 0.01), but not with overall surviv...Continue Reading

References

Apr 27, 2001·Trends in Immunology·H Nishimura, T Honjo
Jul 16, 2002·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Giovanni LanzaLuigi Cavazzini
Jan 24, 2009·British Journal of Cancer·M KoopmanJ H J M van Krieken
Mar 8, 2011·Cell·Douglas Hanahan, Robert A Weinberg
Jun 5, 2012·The New England Journal of Medicine·Suzanne L TopalianMario Sznol
Oct 23, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jeffrey S WeberY Ann Chen
Apr 10, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Janis M TaubeRobert A Anders
Nov 18, 2014·The New England Journal of Medicine·Caroline RobertPaolo A Ascierto
Dec 3, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert J MotzerHans J Hammers
Apr 10, 2015·British Journal of Cancer·B Homet Moreno, A Ribas
Apr 22, 2015·The New England Journal of Medicine·Edward B GaronUNKNOWN KEYNOTE-001 Investigators
Jun 2, 2015·The New England Journal of Medicine·Dung T LeLuis A Diaz
Jun 2, 2015·The New England Journal of Medicine·Julie BrahmerDavid R Spigel
Jan 13, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David F McDermottThomas Powles
Feb 18, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jonathan C DudleyJames R Eshleman
Mar 30, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Zsofia K StadlerLeonard B Saltz
May 10, 2016·The Journal of Clinical Investigation·Janice M MehnertShridar Ganesan
Jul 13, 2016·British Journal of Cancer·Jung Ho KimGyeong Hoon Kang
Oct 28, 2016·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Lik Hang LeeJinru Shia
Aug 20, 2016·JAMA Oncology·Patricia GauleDavid L Rimm
Oct 5, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·David A BraunEliezer M Van Allen
Oct 11, 2016·The New England Journal of Medicine·Martin ReckUNKNOWN KEYNOTE-024 Investigators
Dec 8, 2016·The Lancet Oncology·Geoffrey T GibneyMichael B Atkins

❮ Previous
Next ❯

Citations

Aug 14, 2018·Future Oncology·Fady Gh HaddadMarwan Ghosn
Jan 19, 2019·Journal of Personalized Medicine·David J Hermel, Darren Sigal
Mar 15, 2020·Journal of Leukocyte Biology·Maria Grazia RefoloRosalba D'Alessandro
Mar 25, 2020·Oncotarget·Emanuela Dell'AquilaDaniele Santini
Aug 7, 2019·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Emina TorlakovicMing-Sound Tsao
Aug 27, 2019·Frontiers in Immunology·François Ghiringhelli, Jean-David Fumet
Jan 18, 2019·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Joon Young HurSe Hoon Park
Nov 9, 2018·International Journal of Molecular Sciences·Shravanti MacherlaMahvish Muzaffar
Jul 28, 2019·Cancers·Iranzu González-BorjaJoaquin Fernández-Irigoyen
Feb 6, 2020·Frontiers in Oncology·Stefan KollingFilippo Montemurro
Dec 10, 2019·Molecular and Clinical Oncology·Giovanni PontiMarco Manfredini
Aug 25, 2018·Molecular Cancer·Ming YiKongming Wu
Feb 16, 2019·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Leona A DoyleLynette M Sholl
Feb 6, 2019·Nature Reviews. Gastroenterology & Hepatology·Eric A CollissonAndrew V Biankin
Oct 23, 2020·Molecular Cancer Therapeutics·Brittany A BordenBenedito A Carneiro
Dec 15, 2020·Biochimica Et Biophysica Acta. Reviews on Cancer·Rhys GillmanLionel Hebbard
Jun 8, 2021·Acta Pharmaceutica Sinica. B·Seyed Hossein KiaieBehzad Baradaran
Apr 8, 2021·Histopathology·Suk Wai LamJudith V M G Bovée
Jul 18, 2019·Visceral Medicine·Aline GottliebAli Canbay

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Related Papers

Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
R BendardafS Pyrhönen
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
Sukhmani K PaddaHeather A Wakelee
Expert Opinion on Biological Therapy
Sung Hee LimMyung-Ju Ahn
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
Zaibo LiAdrian A Suarez
© 2022 Meta ULC. All rights reserved